The pre-eclampsia community guideline (PRECOG): How to screen for and detect onset of pre-eclampsia in the community

British Medical Journal

Volumn 330, Issue 7491, 2005, Pages 576-580

  Milne, Fiona ^a   Redman, Chris ^b,c   Walker, James ^d   Baker, Philip ^e   Bradley, Julian ^f   Cooper, Carol ^c   De Swiet, Michael ^c,g   Fletcher, Gillian ^h   Jokinen, Mervi ⁱ   Murphy, Deirdre ^c,j   Nelson Piercy, Catherine ^k   Osgood, Vicky ^l   Robson, Stephen ^m   Shennan, Andrew ^c,k   Tuffnell, Angela ^d   Twaddle, Sara ^a   Waugh, Jason ⁿ  

^a Action on Pre eclampsia   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c Department of Obstetric Medicine ^*

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^e ST MARY S HOSPITAL   (United Kingdom)

^f Stony Stratford Health Centre   (United Kingdom)

^g QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

^h NATIONAL CHILDBIRTH TRUST   (United Kingdom)

ⁱ ROYAL COLLEGE OF MIDWIVES   (United Kingdom)

^j UNIVERSITY OF DUNDEE   (United Kingdom)

^k ST THOMAS HOSPITAL   (United Kingdom)

^l ST MARY S HOSPITAL   (United Kingdom)

^m ROYAL VICTORIA INFIRMARY   (United Kingdom)

ⁿ LEICESTER ROYAL INFIRMARY   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BLOOD PRESSURE; COMMUNITY CARE; FEMALE; HUMAN; HYPERTENSION; MEDICAL SPECIALIST; PATIENT REFERRAL; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY COMPLICATION; PRENATAL CARE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROTEINURIA; REVIEW; RISK ASSESSMENT; SCREENING TEST; ADOLESCENT; ARTICLE; COMMUNITY HEALTH NURSING; DAY CARE; EARLY DIAGNOSIS; HEALTH CARE PLANNING; METHODOLOGY; PREGNANCY; UTILIZATION REVIEW;

ADOLESCENT; ADULT; COMMUNITY HEALTH NURSING; DAY CARE; EARLY DIAGNOSIS; FEMALE; HEALTH RESOURCES; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PRENATAL CARE; REFERRAL AND CONSULTATION; RISK ASSESSMENT;

EID: 20144367499     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.330.7491.576     Document Type: Review

References (24)

1. National Institute for Clinical Excellence, Scottish Executive Health Department, Department of Health, Social Services and Public Safety, Northern Ireland. Why mothers die 2000-2002. The sixth report of the confidential enquiries into maternal deaths in the United Kingdom. London: RCOG Press, 2004.
2. Waters tone M, Bewley S, Wolfe G. Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 2001;322:1089-94.
3. Maternal and Child Health Research Consortium. Confidential enquiry into stillbirths and deaths in infancy: 6th annual report, 1 January-31 December 1997. London: Maternal and Child Health Research Consortium, 1999.
4. The Magpie Trial Collaborative Group. Do women with pre-eclampsia and their babies benefit from magnesium sulphate? The magpie trial: a randomised placebo-controlled trial. Lancet 2002;359:1877-90.
5. Maternal and Child Health Research Consortium. Confidential enquiry into stillbirths and deaths in infancy: 8th annual report, 1 January-31 December 1999. London: Maternal and Child Health Research Consortium, 2001.
6. National Institute for Clinical Excellence, Scottish Executive Health Department, Department of Health, Social Services and Public Safety, Northern Ireland. Why mothers die 1991-1999. The fifth report of the confidential enquiries into maternal deaths in the United Kingdom. London: RCOG Press, 2001.
7. NHS National Institute for Clinical Excellence. The guideline development process-information for national collaborating centres and guideline development groups. Issue Dec 2001. www.nice.org.uk
8. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: a systematic review of controlled studies. BMJ 2005;330:565-7.
9. Stettler RW, Cunningham FG. Natural history of chronic proteinuria complicating pregnancy. Am J Obstet Gynecol 1992;167:1219-24.
10. Koike T, Minakami H, Izumi A, Watanabe T, Matsubara S, Sato I. Recurrence risk of preterm birth due to preeclampsia. Gynecol Obstet Invest 2002;53:22-7.
11. Carroli G, Villar J, Piaggio G, Khan-Neelofur D, Gulmezoglu M, Mugford M, et al. WHO systematic review of randomised controlled trials of routine antenatal care. Lancet 2001;357:1565-70.
12. Abi Said D, Annegers JF, Combs Cantrell D, Frankowski RF, Willmore LJ. Case-control study of the risk factors for eclampsia. Am J Epidemiol 1995;142:437-41.
13. Henderson J, Roberts T, Sikorski J, Wilson J, Clement S. An economic evaluation comparing two schedules of antenatal visits. J Health Serv Res Policy 2000;5:69-75.
14. Banias BB, Devoe LD, Nolan TE. Severe pre-eclampsia in preterm pregnancy between 26 and 32 weeks' gestation. Am J Perinatol 1992;9:357-60.
15. Douglas KA, Redman CW. Eclampsia in ihe United Kingdom. BMJ 1994;309:1395-1400.
16. Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe pre-eclampsia 28 to 32 weeks gestation: a randomised controlled trial. Am J Obstet Gynecol 1994;171:818-22.
17. Barton JR, O'Brien JM, Bergauer NK, Jacques UL, Sibai BM. Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol 2001;184:979-83.
18. Stamilio DM, Sehdev HM, Morgan MA, Propert K, Macones GA. Can antenatal clinical and biochemical markers predict the development of severe pre-eclampsia? Am J Obstet Gynecol 2000;182:589-94.
19. North RA, Taylor RS, Schellenberg JC. Evaluation of a definition of pro-eclampsia. Br J Obstet Gynoecol 1999;106:767-74.
20. Seshadri L, Venkataraman I. Hypertension in pregnancy. Outcomes, proteinuric vs. nonproteinuric. J Reprod Med 1997;42:88-90.
21. Ferrazzani S, Caruso A, De Carolis S, Martino IV, Mancuso S. Proteinuria and outcome of 444 pregnancies complicated by hypertension. Am J Obstet Gynecol 1990;162:366-71.
22. Durnwald C, Mercer B. A prospective comparison of total protein/creatinine ratio versus 24-hour urine protein in women with suspected pre-eclampsia. Am J Obstel Gynecol 2003;189:848-52.
23. Martin JN Jr, May WL, Magann EF, Terrone DA, Rinehart BK, Blake PG. Early risk assessment of severe pre-eclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol 1999;180:1407-14.
24. Witlin AG, Saade GR, Mattar F, Sibai BM. Risk factors for abruptio placentae and eclampsia: analysis of 445 consecutively managed women with severe pre-eclampsia and eclampsia. Am J Obstet Gynecol 1999;180:1322-9.